<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-02-01" modified="2020-10-07" version="252">
<accession>P19838</accession>
<accession>A8K5Y5</accession>
<accession>B3KVE8</accession>
<accession>Q68D84</accession>
<accession>Q86V43</accession>
<accession>Q8N4X7</accession>
<accession>Q9NZC0</accession>
<name>NFKB1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nuclear factor NF-kappa-B p105 subunit</fullName>
</recommendedName>
<alternativeName>
<fullName>DNA-binding factor KBF1</fullName>
</alternativeName>
<alternativeName>
<fullName>EBP-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Nuclear factor NF-kappa-B p50 subunit</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">NFKB1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Cell" volume="62" first="1007" last="1018">
<title>The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.</title>
<authorList>
<person name="Kieran M."/>
<person name="Blank V."/>
<person name="Logeat F."/>
<person name="Vandekerckhove J."/>
<person name="Lottspeich F."/>
<person name="le Bail O."/>
<person name="Urban M.B."/>
<person name="Kourilsky P."/>
<person name="Baeuerle P.A."/>
<person name="Israel A."/>
</authorList>
<dbReference type="PubMed" id="2203531"/>
<dbReference type="DOI" id="10.1016/0092-8674(90)90275-j"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Nature" volume="348" first="76" last="80">
<title>Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.</title>
<authorList>
<person name="Bours V."/>
<person name="Villalobos J."/>
<person name="Burd P.R."/>
<person name="Kelly K."/>
<person name="Siebenlist U."/>
</authorList>
<dbReference type="PubMed" id="2234062"/>
<dbReference type="DOI" id="10.1038/348076a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="966" last="970">
<title>Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.</title>
<authorList>
<person name="Meyer R."/>
<person name="Hatada E.N."/>
<person name="Hohmann H.-P."/>
<person name="Haiker M."/>
<person name="Bartsch C."/>
<person name="Roethlisberger U."/>
<person name="Lahm H.-W."/>
<person name="Schlaeger E.J."/>
<person name="van Loon A.P.G.M."/>
<person name="Scheidereit C."/>
</authorList>
<dbReference type="PubMed" id="1992489"/>
<dbReference type="DOI" id="10.1073/pnas.88.3.966"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="Genomics" volume="30" first="493" last="505">
<title>The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.</title>
<authorList>
<person name="Heron E."/>
<person name="Deloukas P."/>
<person name="van Loon A.P.G.M."/>
</authorList>
<dbReference type="PubMed" id="8825636"/>
<dbReference type="DOI" id="10.1006/geno.1995.1270"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="1999-12" db="EMBL/GenBank/DDBJ databases">
<title>Genome sequencing of the chromosome 4q region implicated in human hepatocellular carcinoma pathogenesis.</title>
<authorList>
<person name="Chang H.-M."/>
<person name="Tsai S.-F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Rectum tumor</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ILE-489; VAL-506; ILE-566; LYS-578; GLN-711 AND THR-901</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Muscle</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1992" name="EMBO J." volume="11" first="205" last="213">
<title>A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.</title>
<authorList>
<person name="Hansen S.K."/>
<person name="Nerlov C."/>
<person name="Zabel U."/>
<person name="Verde P."/>
<person name="Johnsen M."/>
<person name="Baeuerle P.A."/>
<person name="Blasi F."/>
</authorList>
<dbReference type="PubMed" id="1740106"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1992.tb05043.x"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P65-P50 COMPLEX</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="Cell" volume="78" first="773" last="785">
<title>The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.</title>
<authorList>
<person name="Palombella V.J."/>
<person name="Rando O.J."/>
<person name="Goldberg A.L."/>
<person name="Maniatis T."/>
</authorList>
<dbReference type="PubMed" id="8087845"/>
<dbReference type="DOI" id="10.1016/s0092-8674(94)90482-0"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="1487" last="1492">
<title>Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.</title>
<authorList>
<person name="Beg A.A."/>
<person name="Baldwin A.S. Jr."/>
</authorList>
<dbReference type="PubMed" id="8152812"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P50-C-REL COMPLEX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="2248" last="2254">
<title>A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.</title>
<authorList>
<person name="Lin L."/>
<person name="Ghosh S."/>
</authorList>
<dbReference type="PubMed" id="8628291"/>
<dbReference type="DOI" id="10.1128/mcb.16.5.2248"/>
</citation>
<scope>PROTEOLYTIC PROCESSING OF P105</scope>
<scope>GENERATION OF P50 AND P105</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="2236" last="2242">
<title>Inhibition of NF-kappaB DNA binding by nitric oxide.</title>
<authorList>
<person name="Matthews J.R."/>
<person name="Botting C.H."/>
<person name="Panico M."/>
<person name="Morris H.R."/>
<person name="Hay R.T."/>
</authorList>
<dbReference type="PubMed" id="8710491"/>
<dbReference type="DOI" id="10.1093/nar/24.12.2236"/>
</citation>
<scope>S-NITROSYLATION AT CYS-61</scope>
<scope>MUTAGENESIS OF CYS-61</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="6184" last="6190">
<title>A new member of the IkappaB protein family, IkappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.</title>
<authorList>
<person name="Li Z."/>
<person name="Nabel G.J."/>
</authorList>
<dbReference type="PubMed" id="9315679"/>
<dbReference type="DOI" id="10.1128/mcb.17.10.6184"/>
</citation>
<scope>INTERACTION WITH NFKBIE</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Cell" volume="92" first="819" last="828">
<title>Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.</title>
<authorList>
<person name="Lin L."/>
<person name="DeMartino G.N."/>
<person name="Greene W.C."/>
</authorList>
<dbReference type="PubMed" id="9529257"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81409-9"/>
</citation>
<scope>COTRANSLATIONAL FOLDING/PROCESSING OF P105</scope>
<scope>GENERATION OF P50/P105</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="4766" last="4778">
<title>NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.</title>
<authorList>
<person name="Heissmeyer V."/>
<person name="Krappmann D."/>
<person name="Wulczyn F.G."/>
<person name="Scheidereit C."/>
</authorList>
<dbReference type="PubMed" id="10469655"/>
<dbReference type="DOI" id="10.1093/emboj/18.17.4766"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH BCL3</scope>
<scope>MUTAGENESIS OF SER-921; SER-923 AND SER-932</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Nature" volume="397" first="363" last="368">
<title>TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.</title>
<authorList>
<person name="Belich M.P."/>
<person name="Salmeron A."/>
<person name="Johnston L.H."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="9950430"/>
<dbReference type="DOI" id="10.1038/16946"/>
</citation>
<scope>INTERACTION WITH MAP3K8</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="EMBO J." volume="19" first="4712" last="4722">
<title>Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.</title>
<authorList>
<person name="Lin L."/>
<person name="DeMartino G.N."/>
<person name="Greene W.C."/>
</authorList>
<dbReference type="PubMed" id="10970863"/>
<dbReference type="DOI" id="10.1093/emboj/19.17.4712"/>
</citation>
<scope>COTRANSLATIONAL FOLDING/PROCESSING OF P105</scope>
<scope>GENERATION OF P50/P105</scope>
<scope>P50-P105 TRANSIENT HETERODIMER FORMATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="FEBS Lett." volume="485" first="195" last="199">
<title>RAC-3 is a NF-kappa B coactivator.</title>
<authorList>
<person name="Werbajh S."/>
<person name="Nojek I."/>
<person name="Lanz R."/>
<person name="Costas M.A."/>
</authorList>
<dbReference type="PubMed" id="11094166"/>
<dbReference type="DOI" id="10.1016/s0014-5793(00)02223-7"/>
</citation>
<scope>INTERACTION WITH NCOA3</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Biochemistry" volume="40" first="1688" last="1693">
<title>Inhibition of NF-kappaB by S-nitrosylation.</title>
<authorList>
<person name="Marshall H.E."/>
<person name="Stamler J.S."/>
</authorList>
<dbReference type="PubMed" id="11327828"/>
<dbReference type="DOI" id="10.1021/bi002239y"/>
</citation>
<scope>S-NITROSYLATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="Blood" volume="98" first="743" last="753">
<title>Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappa B.</title>
<authorList>
<person name="Ayroldi E."/>
<person name="Migliorati G."/>
<person name="Bruscoli S."/>
<person name="Marchetti C."/>
<person name="Zollo O."/>
<person name="Cannarile L."/>
<person name="D'Adamio F."/>
<person name="Riccardi C."/>
</authorList>
<dbReference type="PubMed" id="11468175"/>
<dbReference type="DOI" id="10.1182/blood.v98.3.743"/>
</citation>
<scope>INTERACTION WITH DSIPI</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="35530" last="35536">
<title>15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit.</title>
<authorList>
<person name="Cernuda-Morollon E."/>
<person name="Pineda-Molina E."/>
<person name="Canada F.J."/>
<person name="Perez-Sala D."/>
</authorList>
<dbReference type="PubMed" id="11466314"/>
<dbReference type="DOI" id="10.1074/jbc.m104518200"/>
</citation>
<scope>LIPIDATION AT CYS-61</scope>
<scope>MUTAGENESIS OF CYS-61</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="22215" last="22222">
<title>Direct phosphorylation of NF-kappa B1 p105 by the Ikappa B kinase complex on serine 927 is essential for signal-induced p105 proteolysis.</title>
<authorList>
<person name="Salmeron A."/>
<person name="Janzen J."/>
<person name="Soneji Y."/>
<person name="Bump N."/>
<person name="Kamens J."/>
<person name="Allen H."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="11297557"/>
<dbReference type="DOI" id="10.1074/jbc.m101754200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-927</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="4917" last="4925">
<title>The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation.</title>
<authorList>
<person name="Heppner C."/>
<person name="Bilimoria K.Y."/>
<person name="Agarwal S.K."/>
<person name="Kester M."/>
<person name="Whitty L.J."/>
<person name="Guru S.C."/>
<person name="Chandrasekharappa S.C."/>
<person name="Collins F.S."/>
<person name="Spiegel A.M."/>
<person name="Marx S.J."/>
<person name="Burns A.L."/>
</authorList>
<dbReference type="PubMed" id="11526476"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204529"/>
</citation>
<scope>INTERACTION WITH MEN1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="309" first="980" last="985">
<title>Casper/c-FLIP is physically and functionally associated with NF-kappaB1 p105.</title>
<authorList>
<person name="Li Z."/>
<person name="Zhang J."/>
<person name="Chen D."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="13679070"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.08.104"/>
</citation>
<scope>INTERACTION WITH CFLAR</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="4973" last="4980">
<title>Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.</title>
<authorList>
<person name="Furia B."/>
<person name="Deng L."/>
<person name="Wu K."/>
<person name="Baylor S."/>
<person name="Kehn K."/>
<person name="Li H."/>
<person name="Donnelly R."/>
<person name="Coleman T."/>
<person name="Kashanchi F."/>
</authorList>
<dbReference type="PubMed" id="11739381"/>
<dbReference type="DOI" id="10.1074/jbc.m107848200"/>
</citation>
<scope>ACETYLATION AT LYS-431; LYS-440 AND LYS-441</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="Blood" volume="101" first="729" last="738">
<title>Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.</title>
<authorList>
<person name="Berrebi D."/>
<person name="Bruscoli S."/>
<person name="Cohen N."/>
<person name="Foussat A."/>
<person name="Migliorati G."/>
<person name="Bouchet-Delbos L."/>
<person name="Maillot M.-C."/>
<person name="Portier A."/>
<person name="Couderc J."/>
<person name="Galanaud P."/>
<person name="Peuchmaur M."/>
<person name="Riccardi C."/>
<person name="Emilie D."/>
</authorList>
<dbReference type="PubMed" id="12393603"/>
<dbReference type="DOI" id="10.1182/blood-2002-02-0538"/>
</citation>
<scope>INTERACTION WITH DSIPI</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="4770" last="4777">
<title>Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation.</title>
<authorList>
<person name="Deng W.G."/>
<person name="Zhu Y."/>
<person name="Wu K.K."/>
</authorList>
<dbReference type="PubMed" id="12471036"/>
<dbReference type="DOI" id="10.1074/jbc.m209286200"/>
</citation>
<scope>ACETYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="39583" last="39590">
<title>Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability.</title>
<authorList>
<person name="Demarchi F."/>
<person name="Bertoli C."/>
<person name="Sandy P."/>
<person name="Schneider C."/>
</authorList>
<dbReference type="PubMed" id="12871932"/>
<dbReference type="DOI" id="10.1074/jbc.m305676200"/>
</citation>
<scope>INTERACTION WITH GSK3B</scope>
<scope>PHOSPHORYLATION AT SER-903 AND SER-907</scope>
<scope>MUTAGENESIS OF SER-903 AND SER-907</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="402" last="413">
<title>betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.</title>
<authorList>
<person name="Lang V."/>
<person name="Janzen J."/>
<person name="Fischer G.Z."/>
<person name="Soneji Y."/>
<person name="Beinke S."/>
<person name="Salmeron A."/>
<person name="Allen H."/>
<person name="Hay R.T."/>
<person name="Ben-Neriah Y."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="12482991"/>
<dbReference type="DOI" id="10.1128/mcb.23.1.402-413.2003"/>
</citation>
<scope>PHOSPHORYLATION AT SER-927 AND SER-932</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="17819" last="17825">
<title>Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB.</title>
<authorList>
<person name="Zhang J."/>
<person name="Xu L.-G."/>
<person name="Han K.-J."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14769797"/>
<dbReference type="DOI" id="10.1074/jbc.m310737200"/>
</citation>
<scope>INTERACTION WITH UNC5CL</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="5235" last="5248">
<title>ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability.</title>
<authorList>
<person name="Lang V."/>
<person name="Symons A."/>
<person name="Watton S.J."/>
<person name="Janzen J."/>
<person name="Soneji Y."/>
<person name="Beinke S."/>
<person name="Howell S."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="15169888"/>
<dbReference type="DOI" id="10.1128/mcb.24.12.5235-5248.2004"/>
</citation>
<scope>INTERACTION WITH MAP3K8 AND TNIP2</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="Infect. Immun." volume="72" first="2582" last="2589">
<title>Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis.</title>
<authorList>
<person name="Guizani-Tabbane L."/>
<person name="Ben-Aissa K."/>
<person name="Belghith M."/>
<person name="Sassi A."/>
<person name="Dellagi K."/>
</authorList>
<dbReference type="PubMed" id="15102766"/>
<dbReference type="DOI" id="10.1128/iai.72.5.2582-2589.2004"/>
</citation>
<scope>IDENTIFICATION IN THE NF-KAPPA-B P50-C-REL COMPLEX</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="9658" last="9667">
<title>Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.</title>
<authorList>
<person name="Beinke S."/>
<person name="Robinson M.J."/>
<person name="Hugunin M."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="15485931"/>
<dbReference type="DOI" id="10.1128/mcb.24.21.9658-9667.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAP3K8</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="Nat. Cell Biol." volume="6" first="97" last="105">
<title>A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.</title>
<authorList>
<person name="Bouwmeester T."/>
<person name="Bauch A."/>
<person name="Ruffner H."/>
<person name="Angrand P.-O."/>
<person name="Bergamini G."/>
<person name="Croughton K."/>
<person name="Cruciat C."/>
<person name="Eberhard D."/>
<person name="Gagneur J."/>
<person name="Ghidelli S."/>
<person name="Hopf C."/>
<person name="Huhse B."/>
<person name="Mangano R."/>
<person name="Michon A.-M."/>
<person name="Schirle M."/>
<person name="Schlegl J."/>
<person name="Schwab M."/>
<person name="Stein M.A."/>
<person name="Bauer A."/>
<person name="Casari G."/>
<person name="Drewes G."/>
<person name="Gavin A.-C."/>
<person name="Jackson D.B."/>
<person name="Joberty G."/>
<person name="Neubauer G."/>
<person name="Rick J."/>
<person name="Kuster B."/>
<person name="Superti-Furga G."/>
</authorList>
<dbReference type="PubMed" id="14743216"/>
<dbReference type="DOI" id="10.1038/ncb1086"/>
</citation>
<scope>INTERACTION WITH SPAG9</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="14767" last="14772">
<title>Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).</title>
<authorList>
<person name="Cockman M.E."/>
<person name="Lancaster D.E."/>
<person name="Stolze I.P."/>
<person name="Hewitson K.S."/>
<person name="McDonough M.A."/>
<person name="Coleman M.L."/>
<person name="Coles C.H."/>
<person name="Yu X."/>
<person name="Hay R.T."/>
<person name="Ley S.C."/>
<person name="Pugh C.W."/>
<person name="Oldham N.J."/>
<person name="Masson N."/>
<person name="Schofield C.J."/>
<person name="Ratcliffe P.J."/>
</authorList>
<dbReference type="PubMed" id="17003112"/>
<dbReference type="DOI" id="10.1073/pnas.0606877103"/>
</citation>
<scope>INTERACTION WITH HIF1AN</scope>
<scope>HYDROXYLATION AT ASN-678</scope>
<scope>MUTAGENESIS OF ASN-678</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-937</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-903 AND SER-907</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-892</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="97" first="389" last="403">
<title>Haploinsufficiency of the NF-kappaB1 Subunit p50 in Common Variable Immunodeficiency.</title>
<authorList>
<person name="Fliegauf M."/>
<person name="Bryant V.L."/>
<person name="Frede N."/>
<person name="Slade C."/>
<person name="Woon S.T."/>
<person name="Lehnert K."/>
<person name="Winzer S."/>
<person name="Bulashevska A."/>
<person name="Scerri T."/>
<person name="Leung E."/>
<person name="Jordan A."/>
<person name="Keller B."/>
<person name="de Vries E."/>
<person name="Cao H."/>
<person name="Yang F."/>
<person name="Schaeffer A.A."/>
<person name="Warnatz K."/>
<person name="Browett P."/>
<person name="Douglass J."/>
<person name="Ameratunga R.V."/>
<person name="van der Meer J.W."/>
<person name="Grimbacher B."/>
</authorList>
<dbReference type="PubMed" id="26279205"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.07.008"/>
</citation>
<scope>INVOLVEMENT IN CVID12</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-325</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1995" name="Nature" volume="373" first="311" last="317">
<title>Structure of the NF-kappa B p50 homodimer bound to DNA.</title>
<authorList>
<person name="Mueller C.W."/>
<person name="Rey F.A."/>
<person name="Sodeoka M."/>
<person name="Verdine G.L."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="7830764"/>
<dbReference type="DOI" id="10.1038/373311a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-365</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1998" name="Cell" volume="95" first="749" last="758">
<title>Structure of an IkappaBalpha/NF-kappaB complex.</title>
<authorList>
<person name="Jacobs M.D."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="9865693"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81698-0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 248-354</scope>
</reference>
<reference key="47">
<citation type="submission" date="2006-12" db="PDB data bank">
<title>Solution structure of the death domain in human nuclear factor NF-kappa-B p105 subunit.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 804-893</scope>
</reference>
<comment type="function">
<text evidence="28">NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.</text>
</comment>
<comment type="subunit">
<text evidence="8 13 14 18 19 20 22 23 24 25 26 27 28 29 30 33 36 37">Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-p50 complex. Homodimer; component of the NF-kappa-B p50-p50 complex. Component of the NF-kappa-B p105-p50 complex. Component of the NF-kappa-B p50-c-Rel complex. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Also interacts with MAP3K8. NF-kappa-B p50 subunit interacts with NCOA3 coactivator, which may coactivate NF-kappa-B dependent expression via its histone acetyltransferase activity. Interacts with DSIPI; this interaction prevents nuclear translocation and DNA-binding. Interacts with SPAG9 and UNC5CL. NFKB1/p105 interacts with CFLAR; the interaction inhibits p105 processing into p50. NFKB1/p105 forms a ternary complex with MAP3K8 and TNIP2. Interacts with GSK3B; the interaction prevents processing of p105 to p50. NFKB1/p50 interacts with NFKBIE. NFKB1/p50 interacts with NFKBIZ. Nuclear factor NF-kappa-B p50 subunit interacts with NFKBID (By similarity). Directly interacts with MEN1. Interacts with HIF1AN.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-3916193">
<id>Q92887</id>
<label>ABCC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-1056534">
<id>P35606</id>
<label>COPB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-301834">
<id>Q13547</id>
<label>HDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-745632">
<id>Q9NWT6</id>
<label>HIF1AN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-354912">
<id>P34931</id>
<label>HSPA1L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-354900">
<id>P41279</id>
<label>MAP3K8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-307326">
<id>Q00653</id>
<label>NFKB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-636374">
<id>P46531</id>
<label>NOTCH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-300028">
<id>Q14690</id>
<label>PDCD11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
<label>PELP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-2689908">
<id>Q8IV08</id>
<label>PLD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-357837">
<id>Q01201</id>
<label>RELB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-351193">
<id>P23396</id>
<label>RPS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-357849">
<id>Q15025</id>
<label>TNIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-359372">
<id>Q8NFZ5</id>
<label>TNIP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-300010">
<id>P19838</id>
</interactant>
<interactant intactId="EBI-1029310">
<id>P10226</id>
<label>UL42</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1452239">
<id>P19838-1</id>
</interactant>
<interactant intactId="EBI-359372">
<id>Q8NFZ5</id>
<label>TNIP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-697771">
<id>PRO_0000030311</id>
</interactant>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-697771">
<id>PRO_0000030311</id>
</interactant>
<interactant intactId="EBI-592789">
<id>O00255</id>
<label>MEN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-697771">
<id>PRO_0000030311</id>
</interactant>
<interactant intactId="EBI-9869387">
<id>O00255-2</id>
<label>MEN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-697771">
<id>PRO_0000030311</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-697771">
<id>PRO_0000030311</id>
</interactant>
<interactant intactId="EBI-1029310">
<id>P10226</id>
<label>UL42</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P19838-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P19838-2</id>
<name>2</name>
<sequence type="described" ref="VSP_021025"/>
</isoform>
<isoform>
<id>P19838-3</id>
<name>3</name>
<sequence type="described" ref="VSP_042869 VSP_042870"/>
</isoform>
</comment>
<comment type="induction">
<text>By phorbol ester and TNF.</text>
</comment>
<comment type="domain">
<text>The C-terminus of p105 might be involved in cytoplasmic retention, inhibition of DNA-binding, and transcription activation.</text>
</comment>
<comment type="domain">
<text>Glycine-rich region (GRR) appears to be a critical element in the generation of p50.</text>
</comment>
<comment type="PTM">
<text evidence="34">While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p50 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.</text>
</comment>
<comment type="PTM">
<text evidence="15 21 22 34">Phosphorylation at 'Ser-903' and 'Ser-907' primes p105 for proteolytic processing in response to TNF-alpha stimulation. Phosphorylation at 'Ser-927' and 'Ser-932' are required for BTRC/BTRCP-mediated proteolysis.</text>
</comment>
<comment type="PTM">
<text evidence="32 34">Polyubiquitination seems to allow p105 processing.</text>
</comment>
<comment type="PTM">
<text evidence="16 35">S-nitrosylation of Cys-61 affects DNA binding.</text>
</comment>
<comment type="PTM">
<text>The covalent modification of cysteine by 15-deoxy-Delta12,14-prostaglandin-J2 is autocatalytic and reversible. It may occur as an alternative to other cysteine modifications, such as S-nitrosylation and S-palmitoylation.</text>
</comment>
<comment type="disease" evidence="31">
<disease id="DI-04553">
<name>Immunodeficiency, common variable, 12</name>
<acronym>CVID12</acronym>
<description>A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen.</description>
<dbReference type="MIM" id="616576"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NFKB1ID323.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/nfkb1/"/>
</comment>
<dbReference type="EMBL" id="M55643">
<property type="protein sequence ID" value="AAA36361.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M58603">
<property type="protein sequence ID" value="AAA36360.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47748">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47749">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47750">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47751">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47752">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47753">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47754">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47755">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47734">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47735">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47736">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47737">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47738">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47739">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47740">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47741">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47742">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47743">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47744">
<property type="protein sequence ID" value="CAB94757.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF213884">
<property type="protein sequence ID" value="AAF35232.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK122850">
<property type="protein sequence ID" value="BAG53760.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291450">
<property type="protein sequence ID" value="BAF84139.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR749522">
<property type="protein sequence ID" value="CAH18336.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY223820">
<property type="protein sequence ID" value="AAO30127.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033210">
<property type="protein sequence ID" value="AAH33210.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC051765">
<property type="protein sequence ID" value="AAH51765.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3657.1">
<molecule id="P19838-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54783.1">
<molecule id="P19838-1"/>
</dbReference>
<dbReference type="PIR" id="A37867">
<property type="entry name" value="A37867"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001158884.1">
<molecule id="P19838-1"/>
<property type="nucleotide sequence ID" value="NM_001165412.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001306155.1">
<molecule id="P19838-1"/>
<property type="nucleotide sequence ID" value="NM_001319226.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003989.2">
<molecule id="P19838-2"/>
<property type="nucleotide sequence ID" value="NM_003998.3"/>
</dbReference>
<dbReference type="PDB" id="1MDI">
<property type="method" value="NMR"/>
<property type="chains" value="B=55-67"/>
</dbReference>
<dbReference type="PDB" id="1MDJ">
<property type="method" value="NMR"/>
<property type="chains" value="B=55-67"/>
</dbReference>
<dbReference type="PDB" id="1MDK">
<property type="method" value="NMR"/>
<property type="chains" value="B=55-67"/>
</dbReference>
<dbReference type="PDB" id="1NFI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="B/D=248-354"/>
</dbReference>
<dbReference type="PDB" id="1SVC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="P=2-365"/>
</dbReference>
<dbReference type="PDB" id="2DBF">
<property type="method" value="NMR"/>
<property type="chains" value="A=806-893"/>
</dbReference>
<dbReference type="PDB" id="2O61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=40-352"/>
</dbReference>
<dbReference type="PDB" id="3GUT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.59"/>
<property type="chains" value="B/D/F/H=41-352"/>
</dbReference>
<dbReference type="PDBsum" id="1MDI"/>
<dbReference type="PDBsum" id="1MDJ"/>
<dbReference type="PDBsum" id="1MDK"/>
<dbReference type="PDBsum" id="1NFI"/>
<dbReference type="PDBsum" id="1SVC"/>
<dbReference type="PDBsum" id="2DBF"/>
<dbReference type="PDBsum" id="2O61"/>
<dbReference type="PDBsum" id="3GUT"/>
<dbReference type="SMR" id="P19838"/>
<dbReference type="BioGRID" id="110857">
<property type="interactions" value="201"/>
</dbReference>
<dbReference type="CORUM" id="P19838"/>
<dbReference type="DIP" id="DIP-106N"/>
<dbReference type="ELM" id="P19838"/>
<dbReference type="IntAct" id="P19838">
<property type="interactions" value="489"/>
</dbReference>
<dbReference type="MINT" id="P19838"/>
<dbReference type="STRING" id="9606.ENSP00000226574"/>
<dbReference type="BindingDB" id="P19838"/>
<dbReference type="ChEMBL" id="CHEMBL3251"/>
<dbReference type="DrugBank" id="DB05767">
<property type="generic name" value="Andrographolide"/>
</dbReference>
<dbReference type="DrugBank" id="DB05487">
<property type="generic name" value="Custirsen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00843">
<property type="generic name" value="Donepezil"/>
</dbReference>
<dbReference type="DrugBank" id="DB13961">
<property type="generic name" value="Fish oil"/>
</dbReference>
<dbReference type="DrugBank" id="DB13751">
<property type="generic name" value="Glycyrrhizic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB05212">
<property type="generic name" value="HE3286"/>
</dbReference>
<dbReference type="DrugBank" id="DB05559">
<property type="generic name" value="NF-kappaB Decoy"/>
</dbReference>
<dbReference type="DrugBank" id="DB05464">
<property type="generic name" value="NOX-700"/>
</dbReference>
<dbReference type="DrugBank" id="DB05451">
<property type="generic name" value="P54"/>
</dbReference>
<dbReference type="DrugBank" id="DB01411">
<property type="generic name" value="Pranlukast"/>
</dbReference>
<dbReference type="DrugBank" id="DB00852">
<property type="generic name" value="Pseudoephedrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB14059">
<property type="generic name" value="SC-236"/>
</dbReference>
<dbReference type="DrugBank" id="DB05471">
<property type="generic name" value="SGN-30"/>
</dbReference>
<dbReference type="DrugBank" id="DB01041">
<property type="generic name" value="Thalidomide"/>
</dbReference>
<dbReference type="DrugBank" id="DB08814">
<property type="generic name" value="Triflusal"/>
</dbReference>
<dbReference type="DrugCentral" id="P19838"/>
<dbReference type="iPTMnet" id="P19838"/>
<dbReference type="MetOSite" id="P19838"/>
<dbReference type="PhosphoSitePlus" id="P19838"/>
<dbReference type="BioMuta" id="NFKB1"/>
<dbReference type="DMDM" id="21542418"/>
<dbReference type="CPTAC" id="CPTAC-1260"/>
<dbReference type="CPTAC" id="CPTAC-1330"/>
<dbReference type="EPD" id="P19838"/>
<dbReference type="jPOST" id="P19838"/>
<dbReference type="MassIVE" id="P19838"/>
<dbReference type="MaxQB" id="P19838"/>
<dbReference type="PaxDb" id="P19838"/>
<dbReference type="PeptideAtlas" id="P19838"/>
<dbReference type="PRIDE" id="P19838"/>
<dbReference type="ProteomicsDB" id="53694">
<molecule id="P19838-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53695">
<molecule id="P19838-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53696">
<molecule id="P19838-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="3415">
<property type="antibodies" value="2305 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4790"/>
<dbReference type="Ensembl" id="ENST00000226574">
<molecule id="P19838-2"/>
<property type="protein sequence ID" value="ENSP00000226574"/>
<property type="gene ID" value="ENSG00000109320"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394820">
<molecule id="P19838-1"/>
<property type="protein sequence ID" value="ENSP00000378297"/>
<property type="gene ID" value="ENSG00000109320"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000505458">
<molecule id="P19838-1"/>
<property type="protein sequence ID" value="ENSP00000424790"/>
<property type="gene ID" value="ENSG00000109320"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000600343">
<molecule id="P19838-3"/>
<property type="protein sequence ID" value="ENSP00000469340"/>
<property type="gene ID" value="ENSG00000109320"/>
</dbReference>
<dbReference type="GeneID" id="4790"/>
<dbReference type="KEGG" id="hsa:4790"/>
<dbReference type="UCSC" id="uc011cep.2">
<molecule id="P19838-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4790"/>
<dbReference type="DisGeNET" id="4790"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000109320.11"/>
<dbReference type="GeneCards" id="NFKB1"/>
<dbReference type="HGNC" id="HGNC:7794">
<property type="gene designation" value="NFKB1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000109320">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NFKB1"/>
<dbReference type="MIM" id="164011">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616576">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P19838"/>
<dbReference type="OpenTargets" id="ENSG00000109320"/>
<dbReference type="Orphanet" id="1572">
<property type="disease" value="Common variable immunodeficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA248"/>
<dbReference type="eggNOG" id="KOG0504">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158625"/>
<dbReference type="HOGENOM" id="CLU_004343_1_0_1"/>
<dbReference type="InParanoid" id="P19838"/>
<dbReference type="KO" id="K02580"/>
<dbReference type="OMA" id="CAIHLAV"/>
<dbReference type="OrthoDB" id="916931at2759"/>
<dbReference type="PhylomeDB" id="P19838"/>
<dbReference type="TreeFam" id="TF325632"/>
<dbReference type="PathwayCommons" id="P19838"/>
<dbReference type="Reactome" id="R-HSA-1169091">
<property type="pathway name" value="Activation of NF-kappaB in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-193692">
<property type="pathway name" value="Regulated proteolysis of p75NTR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209560">
<property type="pathway name" value="NF-kB is activated and signals survival"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559582">
<property type="pathway name" value="Senescence-Associated Secretory Phenotype (SASP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134963">
<property type="pathway name" value="DEx/H-box helicases activate type I IFN and inflammatory cytokines production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214841">
<property type="pathway name" value="PKMTs methylate histone lysines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-448706">
<property type="pathway name" value="Interleukin-1 processing"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603029">
<property type="pathway name" value="IkBA variant leads to EDA-ID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5660668">
<property type="pathway name" value="CLEC7A/inflammasome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5684264">
<property type="pathway name" value="MAP3K8 (TPL2)-dependent MAPK1/3 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-844456">
<property type="pathway name" value="The NLRP3 inflammasome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853884">
<property type="pathway name" value="Transcriptional Regulation by VENTX"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609690">
<property type="pathway name" value="HCMV Early Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9660826">
<property type="pathway name" value="Purinergic signaling in leishmaniasis infection"/>
</dbReference>
<dbReference type="SignaLink" id="P19838"/>
<dbReference type="SIGNOR" id="P19838"/>
<dbReference type="BioGRID-ORCS" id="4790">
<property type="hits" value="13 hits in 901 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NFKB1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P19838"/>
<dbReference type="GeneWiki" id="NFKB1"/>
<dbReference type="GenomeRNAi" id="4790"/>
<dbReference type="Pharos" id="P19838">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P19838"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="P19838">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000109320">
<property type="expression patterns" value="Expressed in bone marrow and 212 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P19838">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P19838">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0033256">
<property type="term" value="C:I-kappaB/NF-kappaB complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034774">
<property type="term" value="C:secretory granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035580">
<property type="term" value="C:specific granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042805">
<property type="term" value="F:actinin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001225">
<property type="term" value="F:RNA polymerase II transcription coactivator binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:1904385">
<property type="term" value="P:cellular response to angiotensin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071359">
<property type="term" value="P:cellular response to dsRNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071347">
<property type="term" value="P:cellular response to interleukin-1"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071354">
<property type="term" value="P:cellular response to interleukin-6"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071316">
<property type="term" value="P:cellular response to nicotine"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031293">
<property type="term" value="P:membrane protein intracellular domain proteolysis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010956">
<property type="term" value="P:negative regulation of calcidiol 1-monooxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032269">
<property type="term" value="P:negative regulation of cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032375">
<property type="term" value="P:negative regulation of cholesterol transport"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032695">
<property type="term" value="P:negative regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010957">
<property type="term" value="P:negative regulation of vitamin D biosynthetic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900127">
<property type="term" value="P:positive regulation of hyaluronan biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010884">
<property type="term" value="P:positive regulation of lipid storage"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010744">
<property type="term" value="P:positive regulation of macrophage derived foam cell differentiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000630">
<property type="term" value="P:positive regulation of miRNA metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035994">
<property type="term" value="P:response to muscle stretch"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051403">
<property type="term" value="P:stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd01177">
<property type="entry name" value="IPT_NFkappaB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.340">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002110">
<property type="entry name" value="Ankyrin_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR020683">
<property type="entry name" value="Ankyrin_rpt-contain_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036770">
<property type="entry name" value="Ankyrin_rpt-contain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000488">
<property type="entry name" value="Death_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR002909">
<property type="entry name" value="IPT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033926">
<property type="entry name" value="IPT_NFkappaB"/>
</dbReference>
<dbReference type="InterPro" id="IPR030503">
<property type="entry name" value="NF-kB_p105"/>
</dbReference>
<dbReference type="InterPro" id="IPR000451">
<property type="entry name" value="NFkB/Dor"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR030492">
<property type="entry name" value="RHD_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR032397">
<property type="entry name" value="RHD_dimer"/>
</dbReference>
<dbReference type="InterPro" id="IPR011539">
<property type="entry name" value="RHD_DNA_bind_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR037059">
<property type="entry name" value="RHD_DNA_bind_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24169">
<property type="entry name" value="PTHR24169"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24169:SF9">
<property type="entry name" value="PTHR24169:SF9"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12796">
<property type="entry name" value="Ank_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00531">
<property type="entry name" value="Death"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16179">
<property type="entry name" value="RHD_dimer"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00554">
<property type="entry name" value="RHD_DNA_bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01415">
<property type="entry name" value="ANKYRIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00057">
<property type="entry name" value="NFKBTNSCPFCT"/>
</dbReference>
<dbReference type="SMART" id="SM00248">
<property type="entry name" value="ANK"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00005">
<property type="entry name" value="DEATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00429">
<property type="entry name" value="IPT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48403">
<property type="entry name" value="SSF48403"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50297">
<property type="entry name" value="ANK_REP_REGION"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50088">
<property type="entry name" value="ANK_REPEAT"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="PROSITE" id="PS01204">
<property type="entry name" value="REL_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50254">
<property type="entry name" value="REL_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0040">ANK repeat</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Nuclear factor NF-kappa-B p105 subunit" id="PRO_0000030310">
<location>
<begin position="1"/>
<end position="968"/>
</location>
</feature>
<feature type="chain" description="Nuclear factor NF-kappa-B p50 subunit" id="PRO_0000030311">
<location>
<begin position="1"/>
<end position="433"/>
</location>
</feature>
<feature type="domain" description="RHD" evidence="12">
<location>
<begin position="42"/>
<end position="367"/>
</location>
</feature>
<feature type="repeat" description="ANK 1">
<location>
<begin position="542"/>
<end position="571"/>
</location>
</feature>
<feature type="repeat" description="ANK 2">
<location>
<begin position="581"/>
<end position="610"/>
</location>
</feature>
<feature type="repeat" description="ANK 3">
<location>
<begin position="614"/>
<end position="643"/>
</location>
</feature>
<feature type="repeat" description="ANK 4">
<location>
<begin position="650"/>
<end position="679"/>
</location>
</feature>
<feature type="repeat" description="ANK 5">
<location>
<begin position="684"/>
<end position="714"/>
</location>
</feature>
<feature type="repeat" description="ANK 6">
<location>
<begin position="718"/>
<end position="747"/>
</location>
</feature>
<feature type="repeat" description="ANK 7">
<location>
<begin position="771"/>
<end position="801"/>
</location>
</feature>
<feature type="domain" description="Death">
<location>
<begin position="805"/>
<end position="892"/>
</location>
</feature>
<feature type="region of interest" description="GRR">
<location>
<begin position="372"/>
<end position="394"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CFLAR" evidence="23">
<location>
<begin position="435"/>
<end position="968"/>
</location>
</feature>
<feature type="region of interest" description="Essential for interaction with HIF1AN" evidence="29">
<location>
<begin position="650"/>
<end position="684"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="11">
<location>
<begin position="360"/>
<end position="365"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="375"/>
<end position="433"/>
</location>
</feature>
<feature type="site" description="Cleavage (when cotranslationally processed)">
<location>
<begin position="433"/>
<end position="434"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine; alternate" evidence="35">
<location>
<position position="61"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="11">
<location>
<position position="337"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EP300" evidence="43">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EP300" evidence="43">
<location>
<position position="440"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EP300" evidence="43">
<location>
<position position="441"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="449"/>
</location>
</feature>
<feature type="modified residue" description="(3S)-3-hydroxyasparagine; by HIF1AN; partial" evidence="29">
<location>
<position position="678"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="759"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="892"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta; in vitro" evidence="5 22">
<location>
<position position="903"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta; in vitro" evidence="5 22">
<location>
<position position="907"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB" evidence="15 21">
<location>
<position position="927"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB" evidence="21">
<location>
<position position="932"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="937"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="943"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine; alternate" evidence="17">
<location>
<position position="61"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="325"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042869" evidence="39">
<location>
<begin position="1"/>
<end position="180"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_021025" evidence="39 40 41">
<original>T</original>
<variation>TA</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042870" evidence="39">
<original>EGGGDRQLG</original>
<variation>MNGLCCMAL</variation>
<location>
<begin position="181"/>
<end position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4648065." id="VAR_016268" evidence="38">
<original>T</original>
<variation>I</variation>
<location>
<position position="489"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4648072." id="VAR_016269" evidence="38">
<original>M</original>
<variation>V</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4648085." id="VAR_016270" evidence="38">
<original>T</original>
<variation>I</variation>
<location>
<position position="566"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4648086." id="VAR_016271" evidence="38">
<original>R</original>
<variation>K</variation>
<location>
<position position="578"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4648099." id="VAR_016272" evidence="38">
<original>H</original>
<variation>Q</variation>
<location>
<position position="711"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4648118." id="VAR_016273" evidence="38">
<original>A</original>
<variation>T</variation>
<location>
<position position="901"/>
</location>
</feature>
<feature type="mutagenesis site" description="Suppresses S-nitrosylation-induced inhibition of DNA-binding activity. Loss of S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine-induced inhibition of DNA-binding activity." evidence="17 35">
<original>C</original>
<variation>S</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Fails to promote HIF1AN-dependent 2-oxoglutarate decarboxylation." evidence="29">
<original>N</original>
<variation>A</variation>
<location>
<position position="678"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents p105 proteolysis in response to TNF-alpha." evidence="22">
<original>S</original>
<variation>A</variation>
<location>
<position position="903"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents p105 proteolysis in response to TNF-alpha." evidence="22">
<original>S</original>
<variation>A</variation>
<location>
<position position="907"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-923 and A-932." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="921"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-921 and A-932." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="923"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-921 and A-923." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="932"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAB94757." ref="4" evidence="42">
<original>K</original>
<variation>SE</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAH18336." ref="7" evidence="42">
<original>R</original>
<variation>G</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAB94757." ref="4" evidence="42">
<original>II</original>
<variation>SS</variation>
<location>
<begin position="551"/>
<end position="552"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAF84139." ref="6" evidence="42">
<original>D</original>
<variation>G</variation>
<location>
<position position="573"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAB94757." ref="4" evidence="42">
<original>A</original>
<variation>V</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAH18336." ref="7" evidence="42">
<original>I</original>
<variation>T</variation>
<location>
<position position="825"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAB94757." ref="4" evidence="42">
<original>V</original>
<variation>I</variation>
<location>
<position position="869"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36361, 3; AAA36360 and 4; CAB94757." ref="1 3 4" evidence="42">
<original>S</original>
<variation>T</variation>
<location>
<position position="927"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="43"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="52"/>
<end position="54"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="60"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="83"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="94"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="103"/>
<end position="105"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="110"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="122"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="138"/>
<end position="143"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="149"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="167"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="173"/>
<end position="178"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="184"/>
<end position="187"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="190"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="211"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="227"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="234"/>
<end position="240"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="245"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="252"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="258"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="267"/>
<end position="274"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="281"/>
<end position="288"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="292"/>
<end position="297"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="302"/>
<end position="304"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="307"/>
<end position="309"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="310"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="319"/>
<end position="322"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="327"/>
<end position="334"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="336"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="345"/>
<end position="350"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="813"/>
<end position="823"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="832"/>
<end position="839"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="842"/>
<end position="844"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="845"/>
<end position="850"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="854"/>
<end position="864"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="869"/>
<end position="879"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="883"/>
<end position="892"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1SVC"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DBF"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2O61"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P25799"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q63369"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00265"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10469655"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11094166"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11297557"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11327828"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11466314"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11468175"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11526476"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12393603"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12482991"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12871932"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="13679070"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14743216"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14769797"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15102766"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15169888"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15485931"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17003112"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1740106"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26279205"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8087845"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8152812"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8628291"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8710491"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9315679"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9950430"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2203531"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000305"/>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11739381"/>
</source>
</evidence>
<sequence length="968" mass="105356" checksum="2A7C8FF86A10D1A8" modified="2002-06-20" version="2">MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

